Eroxon
Commercial- Indications
- Erectile dysfunction
Company intelligence / Profile preview
Futura Medical plc
Guildford, Surrey, United Kingdomfuturamedical.com ↗
- Ownership
- Private
- Employees
- ~14
- Development stage
- Commercial
01
Overview
Lead product Eroxon (MED3000) is FDA-approved and clinically proven to help men achieve an erection within 10 minutes. Available without prescription in Europe and in the US since October 2024.
- Therapeutic areas
- Men's HealthWomen's Health
- Modalities
- Topical gel formulations
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Haleon plc (USA)Cooper Consumer Health (Europe)
Beyond the preview
Go deeper on Futura Medical plc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Futura Medical plc.